Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma.

被引：0
|
作者：
Ilson, D. [1 ]
Shah, M. A. [1 ]
Kelsen, D. P. [1 ]
Janjigian, Y. Y. [1 ]
Tang, L. H. [1 ]
Campbell, J. [1 ]
Fuqua, L. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14668
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Various clinical outcomes in patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications.
    Suzuki, Akihiro
    Xiao, Lianchun
    Taketa, Takashi
    Sudo, Kazuki
    Blum, Mariela A.
    Komaki, Ritsuko
    Lee, Jeffrey H.
    Bhutani, Manoop S.
    Weston, Brian
    Hofstetter, Wayne Lewis
    Swisher, Stephen
    Ajani, Jaffer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction and gastric adenocarcinoma.
    Okamura, Ryosuke
    Kato, Shumei
    Baumgartner, Joel Micah
    Patel, Hitendra
    Leichman, Lawrence P.
    Kelly, Kaitlyn J.
    Fanta, Paul T.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Phase I study of fluzoparib, a PARP1 Inhibitor in combination with apatinib and paclitaxel in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
    Xu, Jian-Ming
    Liu, Rongrui
    Ba, Yi
    Jiang, Da
    Wang, Mingxia
    Zheng, Yulong
    Wei, Jia
    Bai, Yu-Xian
    Lin, Lizhu
    Xiong, Jianping
    Zhu, Xixi
    Zhao, Chuanhua
    Jia, Ru
    Zhang, Yun
    Liu, Jianzhi
    Zhang, Gairong
    Li, Guangze
    Wang, Quanren
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
    Sun, Weijing
    Veeramachaneni, Nirmal
    Al-Rajabi, Raed
    Madan, Rashna
    Kasi, Anup
    Al-Kasspooles, Mazin
    Baranda, Joaquina
    Saeed, Anwaar
    Phadnis, Milind A. A.
    Godwin, Andrew K. K.
    Olyaee, Mojtaba
    Streeter, Natalie
    Nagji, Alykhan
    Dai, Junqiang
    Williamson, Stephen
    CANCER MEDICINE, 2023, 12 (15): : 16098 - 16107
  • [45] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Mackay, Helen J.
    Au, Heather J.
    McWhirter, Elaine
    Alcindor, Thierry
    Jarvi, Andrea
    MacAlpine, Katrina
    Wang, Lisa
    Wright, John J.
    Oza, Amit M.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1158 - 1163
  • [46] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Helen J. Mackay
    Heather J. Au
    Elaine McWhirter
    Thierry Alcindor
    Andrea Jarvi
    Katrina MacAlpine
    Lisa Wang
    John J. Wright
    Amit M. Oza
    Investigational New Drugs, 2012, 30 : 1158 - 1163
  • [47] A phase 2 trial of chemotherapy, pembrolizumab, and propranolol in patients with advanced esophageal/gastroesophageal junction adenocarcinoma (EGAC)
    Mukherjee, Sarbajit
    Jatwani, Karan
    Chatley, Sarah
    Fountzilas, Christos
    Velasco, Sylvia Vania Alarcon
    Vadehra, Deepak
    Iyer, Renuka V.
    Attwood, Kristopher
    Farrugia, Mark
    Singh, Anurag K.
    Repasky, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)
    Li, J.
    Luo, S.
    Liu, T.
    Dong, L.
    Yuan, X.
    Feng, J.
    Wang, Y.
    Deng, Y.
    Chen, J.
    Zhang, M.
    Zhou, H.
    Cao, Y.
    Qiu, W.
    Ren, X.
    Cai, S.
    Dong, Y.
    Wang, W.
    Shen, Y.
    Dou, N.
    Huang, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S478 - S478
  • [49] A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
    Mamdani, Hirva
    Schneider, Bryan
    Perkins, Susan M.
    Burney, Heather N.
    Kasi, Pashtoon Murtaza
    Abushahin, Laith, I
    Birdas, Thomas
    Kesler, Kenneth
    Watkins, Tracy M.
    Badve, Sunil S.
    Radovich, Milan
    Jalal, Shadia, I
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
    Shi, Jin-Ming
    Li, Ning
    Jiang, Li-Ming
    Yang, Lin
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Fang, Hui
    Lu, Ning-Ning
    Qi, Shu-Nan
    Chen, Bo
    Li, Ye-Xiong
    Zhao, Dong-Bing
    Tang, Yuan
    Jin, Jing
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345